Compound | Reference | Concentration | Formula | Exposure | Method | Viral titer reduction |
---|---|---|---|---|---|---|
PVP-I | 0.45-10% | Oral spray, oral rinse, skin antiseptics | 30s | O | ||
0.5-1.0% | Oral rinse | 15-60s | O | |||
0.5-1.5% | Oral rinse | 15-30s | O | |||
0.17-0.9% | Nasal spray, eye drop | 30s-10m | O | |||
0.5-2.5% | Nasal spray | 15-30s | O | |||
1% | Oral rinse | 1m | O | |||
Chlorhexidine | 0.12% | Oral rinse | 30s | Δ (temporary) | ||
Hydrogen peroxide | 1.5-3% | Oral rinse | 15-30s | X | ||
0.2% | Oral rinse | 30s | X | |||
1% | Oral rinse | 30s | X | |||
Alcohol & essential oils | 21% ethanol etc. | Oral rinse | 30s | O | ||
Hypertonic saline | 1.5-1.7% | Mixed solution | 1-72h | O | ||
Iota-carrageenan | 6-600μg/mL + 50mg/mL xylitol | Nasal rinse | 2h | O |